Pharmafile Logo
Pharmafocus logo
Advanced Search

vaccines

Showing 15 posts of 191 posts found.

Merck plans to conduct trials for HPV vaccines

March 13, 2024
Research and Development Immunology, Merck, vaccines

Merck, known as MSD outside of the US and Canada, has announced that it is planning to initiate clinical development …

News

Measles: the UK’s next epidemic?

March 6, 2024
MMR, measles, vaccines

Recently, the UK has seen a rapid increase in the number of cases of measles, along with a drop in …

Feature

AstraZeneca to acquire Icosavax for up to $1.1bn

December 12, 2023
Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …

News

Janssen and Sanofi enter agreement for potential vaccine programme

October 5, 2023
Business Services Immunology, Janssen, Sanofi, e coli, vaccines

Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …

News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine

October 5, 2023
Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines

Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …

News

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023
Research and Development AMR, BactiVac, Immunology, vaccines

The University of Birmingham hosted Bacterial Vaccines Network has been awarded £1.4m in funding from the UK government to accelerate …

News

GSK and Save the Children extend partnership for unvaccinated children

September 15, 2023
Medical Communications GSK, Immunology, childhood vaccination, vaccines

GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK …

News

Vaxxas opens manufacturing facility for needle-free vaccine patch

June 19, 2023
Research and Development Immunology, Vaxxas, manufacturing, needle-free vaccines, vaccines

Clinical stage biotech company Vaxxas has announced that it is opening a biomedical manufacturing facility in Brisbane, Australia, for the …

News

CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates

May 9, 2023
Medical Communications CureVac, GSK, Virology, clinical trial, mrna, vaccines

CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …

News

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021
Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …

News

UK COVID vaccine update

June 16, 2021
Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …

News

World’s first COVID-19 vaccine booster study launches in UK

May 20, 2021
COVID-19, UK government, booster vaccine, clinical trial, vaccines

The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, …

News

Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains

March 12, 2021
Medical Communications COVID-19, Novavax, vaccines

Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …

News
lonza

Altimmune expands COVID-19 vaccine manufacturing deal with Lonza

March 12, 2021
Medical Communications Altimmune, COVID-19, Lonza, vaccines

Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …

News

Affinivax receives $22m funding for development of Staphylococcus aureus vaccine

March 10, 2021
Research and Development Affinivax, bacteria, vaccines

Affinivax has received an award of $22 million funding from CARB-X, a global non-profit organisation, to develop a vaccine targeting Staphylococcus …

News

Latest content

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024

Sarepta Therapeutics gains expanded FDA approval for DMD treatment

June 21, 2024

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024